“After the vaccine has been demonstrated to be secure and successful [after diagnosis outcomes are published at November]the vaccine will be made available on the marketplace by December [2020] or January the following year,” Guo Guangchangand seat of the parent firm of Fosun Pharmaceuticals, said Tuesday in the Fortune International Forum. There’s also, of course, no guarantee […]
